ZA985501B - Chromene compounds a process for their preparation and pharmaceutical compositions containing them - Google Patents

Chromene compounds a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA985501B
ZA985501B ZA985501A ZA985501A ZA985501B ZA 985501 B ZA985501 B ZA 985501B ZA 985501 A ZA985501 A ZA 985501A ZA 985501 A ZA985501 A ZA 985501A ZA 985501 B ZA985501 B ZA 985501B
Authority
ZA
South Africa
Prior art keywords
alkyl
sigma bond
optionally substituted
heteroaryl
phenyl
Prior art date
Application number
ZA985501A
Other languages
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Patrick Hautefaye
Francoise Lejeune
Mark Millan
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA985501B publication Critical patent/ZA985501B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA985501A 1997-06-24 1998-06-24 Chromene compounds a process for their preparation and pharmaceutical compositions containing them ZA985501B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707839A FR2764890B1 (fr) 1997-06-24 1997-06-24 Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA985501B true ZA985501B (en) 1999-01-20

Family

ID=9508333

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985501A ZA985501B (en) 1997-06-24 1998-06-24 Chromene compounds a process for their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (3) US6090837A (no)
EP (1) EP0887350B1 (no)
JP (1) JP4065604B2 (no)
CN (1) CN1100057C (no)
AT (1) ATE204578T1 (no)
AU (1) AU735062B2 (no)
BR (1) BR9802212A (no)
CA (1) CA2242015C (no)
DE (1) DE69801400T2 (no)
DK (1) DK0887350T3 (no)
ES (1) ES2163239T3 (no)
FR (1) FR2764890B1 (no)
GR (1) GR3037038T3 (no)
HK (1) HK1016987A1 (no)
HU (1) HU222728B1 (no)
NO (1) NO323575B1 (no)
NZ (1) NZ330787A (no)
PL (1) PL192783B1 (no)
PT (1) PT887350E (no)
ZA (1) ZA985501B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134477A (en) * 1990-12-11 1992-07-28 At&T Bell Laboratories Hdtv receiver
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AR022230A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
FR2823752B1 (fr) * 2001-04-18 2004-10-22 Servier Lab Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7087636B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
TW200400818A (en) 2002-05-21 2004-01-16 Wyeth Corp Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
TW200400963A (en) 2002-05-21 2004-01-16 Wyeth Corp R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
US7765162B2 (en) * 2002-10-07 2010-07-27 Mastercard International Incorporated Method and system for conducting off-line and on-line pre-authorized payment transactions
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
WO2007098462A2 (en) * 2006-02-21 2007-08-30 Purdue Research Foundation Trans-fused chromenoisoquinolines, synthesis and methods for use
WO2010124005A1 (en) 2009-04-21 2010-10-28 Purdue Research Foundation Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
FR2948372B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN111647003B (zh) * 2020-06-08 2022-06-21 中国科学院昆明植物研究所 三环氧六氢色酮a及其药物组合物和其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722194B1 (fr) * 1994-07-06 1996-08-23 Adir Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PL192783B1 (pl) 2006-12-29
EP0887350B1 (fr) 2001-08-22
CA2242015C (fr) 2005-01-04
JP4065604B2 (ja) 2008-03-26
US6365605B1 (en) 2002-04-02
US6090837A (en) 2000-07-18
HU222728B1 (hu) 2003-09-29
FR2764890A1 (fr) 1998-12-24
AU735062B2 (en) 2001-06-28
HUP9801423A3 (en) 1999-04-28
ES2163239T3 (es) 2002-01-16
NZ330787A (en) 1999-04-29
HUP9801423A2 (hu) 1999-03-29
BR9802212A (pt) 1999-05-25
US6326377B1 (en) 2001-12-04
CA2242015A1 (fr) 1998-12-24
CN1100057C (zh) 2003-01-29
DE69801400T2 (de) 2002-05-16
PT887350E (pt) 2001-11-30
HU9801423D0 (en) 1998-08-28
FR2764890B1 (fr) 1999-08-27
DE69801400D1 (de) 2001-09-27
HK1016987A1 (en) 1999-11-12
ATE204578T1 (de) 2001-09-15
NO982921D0 (no) 1998-06-23
NO982921L (no) 1998-12-28
EP0887350A1 (fr) 1998-12-30
NO323575B1 (no) 2007-06-11
GR3037038T3 (en) 2002-01-31
DK0887350T3 (da) 2001-10-08
CN1203235A (zh) 1998-12-30
JPH1171376A (ja) 1999-03-16
AU7314098A (en) 1999-01-07
PL327002A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
ZA985501B (en) Chromene compounds a process for their preparation and pharmaceutical compositions containing them
UA41358C2 (uk) Похідні імідазопіридинів, спосіб їх одержання, фармацевтичний склад та спосіб його одержання
ATE135390T1 (de) Anionische verbindungen
ES8606322A1 (es) Procedimiento para preparar derivados de benzodifuranona
ES2076471T3 (es) Compuestos anionicos.
ATE246196T1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
CZ103595A3 (en) Derivative of 3-indolylpiperidine, process of its preparation, its use for preparing a pharmaceutical preparation and and the pharmaceutical composition containing thereof
ZA964484B (en) Alkoxyaryl compounds their process of preparation and the pharmaceutical compositions which contain them
MY113518A (en) Benzothiazolone derivatives
AU4872793A (en) New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
TW333532B (en) Benzopyrans
HK1014956A1 (en) Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE281452T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE191483T1 (de) Trizyklische oximether, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL99244A0 (en) Penem compounds
ATE94050T1 (de) Mittel zur verhinderung von zahnbelagbildung.
DE60001186D1 (de) Benzylaminodiacetamidderivate, Zusammensetzungen, die diese enthalten, Verfahren zu ihrer Herstellung und Anwendungen
ATE281453T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DK460789A (da) 2-aminoacetamidderivater